All data are based on the daily closing price as of August 12, 2025
v

Vital KSK Holdings

3151.TSE
8.52 USD
-0.02
-0.23%

Overview

Last close
8.52 usd
Market cap
412.04M usd
52 week high
9.70 usd
52 week low
7.07 usd
Target price
N/A usd

Valuation

P/E
8.4737
Forward P/E
N/A
Price/Sales
0.1014
Price/Book Value
0.5849
Enterprise Value
290.59M usd
EV/Revenue
0.0718
EV/EBITDA
2.962

Key financials

Revenue TTM
4.06B usd
Gross Profit TTM
332.78M usd
EBITDA TTM
61.79M usd
Earnings per Share
1 usd
Dividend
0.3 usd
Total assets
2.01B usd
Net debt
-97.30M usd

About

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. It operates through Pharmaceutical Wholesale Business; Pharmacy Business; Veterinary Drug Wholesale Business; and Other Businesses. The company is involved in the nursing care; agrochemical wholesale; and sale of pharmaceuticals, poisonous or deleterious substances, narcotics, quasi-drugs, vaccines, paints, pigments, dyes, medical equipment, sanitary materials, hygiene goods, nursing care products, and beverages. It also engages in the medical and pharmacy consulting business; general freight vehicle transportation; and insurance agency, real estate management, and parking lot operation. Vital KSK Holdings, Inc. was incorporated in 2009 and is headquartered in Setagaya, Japan.
  • Symbol
    3151.TSE
  • Exchange
    TSE
  • Isin
    JP3778280002
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Medical Distribution
  • CEO
    Mr. Taisuke Murai
  • Headquarter
    Setagaya
  • Web site
    https://www.vitalksk.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top